作者
Ettore Beghi, Raimund Helbok, Serefnur Ozturk, Omer Karadas, Vitalie Lisnic, Oxana Grosu, Tibor Kovács, Levente Dobronyi, Daniel Bereczki, Maria Sofia Cotelli, Marinella Turla, Eugenia Irene Davidescu, Bogdan Ovidiu Popescu, Franco Valzania, Francesco Cavallieri, Hanno Ulmer, Luis F Maia, Anne Hege Amodt, Carmel Armon, Waldemer Brola, Gryb Victoria, Anis Riahi, Ingomar Krehan, Tim von Oertzen, Mohammed A Azab, Michael Crean, Maria Lolich, Maria João Lima, Johann Sellner, Julian Perneczky, Tom Jenkins, Sara Meoni, Elisa Bianchi, Elena Moro, Claudio LA Bassetti, ENERGY Study Group, Onur Ural, Iskender Kara, Bilgin Ozturk, Mihail Gavriliuc, Olesea Odainic, Patrizia Civelli, Marta Bianchi, Teodora Bunea, Georgiana Sandu, Giulia Toschi, Vanessa Oliveira, Alexandre Dias, Simon Jung, Robert Hoepner, Marion Boldingh, Netta Agajany, Sharon Wolfson, Lipowski Michał, Lesiv Marjiana, Hajer Derbali, Mafalda Seabra, Vanessa Carvalho, Heidi Øyen Flemmen, Clarissa Lin Yasuda, Pille Taba, Osama Yassin, Gordana Kiteva‐Trenchevska
发表日期
2022/6
期刊
European journal of neurology
卷号
29
期号
6
页码范围
1663-1684
简介
Background and purpose
Despite the increasing number of reports on the spectrum of neurological manifestations of COVID‐19 (neuro‐COVID), few studies have assessed short‐ and long‐term outcome of the disease.
Methods
This is a cohort study enrolling adult patients with neuro‐COVID seen in neurological consultation. Data were collected prospectively or retrospectively in the European Academy of Neurology NEuro‐covid ReGistrY ((ENERGY). The outcome at discharge was measured using the modified Rankin Scale and defined as ‘stable/improved’ if the modified Rankin Scale score was equal to or lower than the pre‐morbid score, ‘worse’ if the score was higher than the pre‐morbid score. Status at 6 months was also recorded. Demographic and clinical variables were assessed as predictors of outcome at discharge and 6 months.
Results
From July 2020 to March 2021, 971 patients from 19 …
引用总数
学术搜索中的文章